ISA Pharmaceuticals Closes €26M Funding Round

14 Jul, 2021

ISA Pharmaceuticals Closes €26M Funding Round
Photo by Xrdes on Unsplash

– ISA Pharmaceuticals B.V. from Oegstgeest, The Netherlands closed a €26m funding round.
– Backers included new investor – Invest-NL and existing investors including Regeneron.
– The company intends to use the funds to advance the lead product ISA101b towards first marketing authorization as well as to broaden the clinical pipeline of immunotherapies based on the Synthetic Long Peptide (SLP®) platform technology.

Biotechnology Medical Western Europe
Crunchbase icon

Content report

The following text will be sent to our editors: